DSpace logo

Search


Start a new search
Add filters:

Use filters to refine the search results.


Results 17121-17130 of 17990 (Search time: 0.017 seconds).
Item hits:
Issue DateTitleAuthor(s)
2025-01Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implicationsTaliyan, Rajeev
2024-11Oxidized ionic polysaccharide hydrogels: review on derived scaffolds characteristics and tissue engineering applicationsPandey, Murali Monohar
2025Design aspects, development, and sensitivity analysis of gan hemt-based biosensing platform for label-free detection of interleukin-6Taliyan, Rajeev
2024-11The TRPC5 receptor as pharmacological target for pain and metabolic diseaseKhare, Pragyanshu
2024-04In situ bioprinting: process, bioinks, and applicationsPandey, Murali Monohar
2024Nanoparticle-based materials for wound managementPandey, Murali Monohar
2024-07Topical menthol, a pharmacological cold mimic, induces cold sensitivity, adaptive thermogenesis and brown adipose tissue activation in miceKhare, Pragyanshu
2025-01Millions of people worldwide are negatively impacted by a diverse range of brain conditions known as neurodegenerative diseases. The work reports a GaN HEMT-based biosensing system for the early detection and monitoring of neurodegenerative disease biomarkers in clinically relevant concentration ranges. The developed system offers a high sensitivity of 19.40 µA/pg/ml, 0.52 mA/pg/ml, 0.69 mA/ng/ml, 0.13 mA/pg/ml, 23.66 µA/pg/ml, and 23.85 µA/pg/ml for the detection of UCH-L1, GFAP, S100B, IL-6, Aβ, and IFN-γ respectively. The proposed biofunctionalization assay has an excellent specificity and selectivity, signal-to-noise ratio of 1:16, 1:23, and 1:38 for UCH-L1, GFAP, and S100B detection respectively with a LoD of 0.06 fg/ml. The platform has good repeatability with an average sensitivity of 19.41 µA/pg/ml, 0.524 mA/pg/ml, and 0.704 mA/ng/ml for UCH-L1, GFAP, and S100B detection respectively. The sensors have a very good shelf-life for a storage time of 35 days with reductions of 1.39 %, 1.72 %, and 2.05 % in sensor response and 2.88 %, 2.76 %, and 2.96 % in sensitivity for UCH-L1, GFAP, and S100B respectively. The coefficient of variation (CV) values for conventional and meander-gated GaN HEMT biosensors were found to be ∼0.038 and ∼0.026 respectively. A slight variation of ∼4.41 % in sensor response when the sensor was reused clearly demonstrates the sensor’s reusability. A very high resolution with detection capability in the ultra-low concentration of fg/ml with good linearity and quantifiable sensor response which is a key requirement for early-stage detection of diseases has been observed for sensor design with source-to-drain distance () of 10 µm. Thus, the platform capability and suitability for early detection and prognosis of neurodegenerative disease detection and monitoring have been demonstrated. Further, the system can be imperative in patient screening in clinical, sports, and warfare for CT or MRI scan requirements.Taliyan, Rajeev
2024-06Pharmacokinetic and Biodistribution Studies of Camel Milk Casein Nanoparticles Loaded Sorafenib in Swiss Albino MiceTaliyan, Rajeev; Dubey, Uma S.
2024-11Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lensSinghvi, Gautam; Taliyan, Rajeev